Source comparison
Semax: Research and Clinical Comparison
Below is a comparison of Semax against other cognitive and neuroprotective compounds frequently studied in similar contexts. This is not a recommendation. It's a structured overview of mechanism, half-life, and typical use cases based on published research. Se
This comparison does not assign a generated winner or score.
- Below is a comparison of Semax against other cognitive and neuroprotective compounds frequently studied in similar contexts. This is not a recommendation. It's a structured overview of mechanism, half-life, and typical use cases based on published research.
- Semax
- BDNF/NGF upregulation via ACTH(4-10) analogue; MAO-A inhibition
- ~30 minutes (effects persist 8–12 hours)
- 300–900 mcg/day intranasal
- Stroke recovery, ADHD, cognitive resilience
- Best evidence for neuroprotection and recovery; minimal acute cognitive boost in healthy populations
- Noopept
- Glutamatergic modulation; cycloprolylglycine metabolite increases BDNF
- 25 minutes
- 10–30 mg oral
- Memory enhancement, anxiolytic
- Faster-acting but shorter neurotrophin effect; more pronounced in anxious phenotypes
- Cerebrolysin
- Porcine-derived neurotrophic peptides (BDNF, NGF, CNTF)
- Variable (peptide mixture)
- 10–30 mL IV infusion
- Post-stroke, dementia, TBI
- More invasive administration; stronger clinical evidence base in neurodegenerative disorders
- Dihexa
- HGF/c-Met pathway agonist; potent synaptogenic compound
- ~3 hours
- 5–10 mg oral (preclinical dosing)
- Cognitive decline, neurodegenerative research
- Strongest preclinical synaptogenesis data; human clinical trials still in early phases
- Selank
- Tuftsin analogue; modulates IL-6, MAO, serotonin metabolism
- ~30 minutes
- 250–500 mcg intranasal
- Anxiety, immune modulation
- Primarily anxiolytic; cognitive benefit secondary to stress reduction
- Semax occupies a distinct niche: it's not the most potent acute cognitive enhancer, but it has the strongest clinical evidence for neuroprotection during ischemic or metabolic stress. The neurotrophin upregulation mechanism makes it more of a long-term resilience compound than a performance-on-demand nootropic. Dihexa shows more dramatic synaptogenesis in preclinical models, but Semax has decades of human clinical use data. A critical distinction when evaluating safety and reproducibility.